Results 141 to 150 of about 1,100,787 (194)

The Bruton tyrosine kinase inhibitor zanubrutinib (BGB-3111) demonstrated synergies with other anti-lymphoma targeted agents

Haematologica, 2019
Chiara Tarantelli, Lu Zhang, Elisabetta Curti, Eugenio Gaudio, Filippo Spriano, Valdemar Priebe, Luciano Cascione, Alberto J. Arribas, Emanuele Zucca, Davide Rossi, Anastasios Stathis, Francesco Bertoni   +11 more
doaj   +1 more source

The Bruton tyrosine kinase inhibitor acalabrutinib aborts ongoing acute food-induced anaphylactic reactions in humanized mice. [PDF]

J Allergy Clin Immunol
Arce B, Vilela NM, Chichester KL, Sokol KA, Alvarez-Arango S, Iacobelli L, Oliver ET, Croote D, Bochner BS, MacGlashan DW, Dispenza MC.   +10 more
europepmc   +1 more source

A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma. [PDF]

Sci Rep
Ding Y, Huang K, Sun C, Liu Z, Zhu J, Jiao X, Liao Y, Feng X, Guo J, Zhu C, Zhai Z, Xiong S.   +11 more
europepmc   +1 more source

The Bruton tyrosine kinase inhibitor ibrutinib improves anti-MAG antibody polyneuropathy. [PDF]

Neurol Neuroimmunol Neuroinflamm, 2020
Castellani F, Visentin A, Campagnolo M, Salvalaggio A, Cacciavillani M, Candiotto C, Bertorelle R, Trentin L, Briani C.   +8 more
europepmc   +1 more source

Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. [PDF]

JCO Oncol Pract
Fakhri B, Emechebe N, Manzoor BS, Jawaid D, Alhasani H, Edwards M, Tuncer HH.   +6 more
europepmc   +1 more source

Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor. [PDF]

Adv Ther
Salles G, Chen JMH, Zhang I, Kerbauy F, Wu JJ, Wade SW, Nunes A, Feng C, Kloos I, Peng W, Snider JT, Maciel D, Chan K, Keeping S, Shah B.   +14 more
europepmc   +1 more source